{"id":"W4412488898","doi":"10.1182/bloodadvances.2024014654","title":"Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti–PD-1–refractory Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"Pembrolizumab; Medicine; Refractory (planetary science); Internal medicine; Clinical trial; Lesion; Oncology; Gastroenterology; Surgery; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02131373,0.0007589557,0.001784007,0.00076742,0.0001851177,0.0007126541,0.0008102877,0.0009327289,0.001508015],"category_scores_gemma":[0.0237422,0.0004480469,0.002492578,0.000517364,0.000322105,0.0008116485,0.0007908707,0.00107591,0.0002558986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006718286,"about_ca_system_score_gemma":0.0003518266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006707208,"about_ca_topic_score_gemma":0.0005781992,"domain_scores_codex":[0.9890297,0.007793492,0.0007811156,0.00132187,0.000869681,0.0002041773],"domain_scores_gemma":[0.9781415,0.01624508,0.003482722,0.0008489697,0.0008184497,0.000463299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3524713,0.001953116,0.5059974,0.002849703,0.0303449,0.0001644859,0.0007953986,0.01291385,0.01222984,0.0003431855,0.0009481083,0.07898878],"study_design_scores_gemma":[0.01775231,0.09932883,0.8042238,0.0004279564,0.02289832,0.0005801598,0.0005349353,0.0399841,0.009753954,0.0008055773,0.003548988,0.0001611937],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949383,0.002485553,0.001252522,0.00005450901,0.00002877937,0.0002387279,0.0005256329,0.00002108407,0.0004548801],"genre_scores_gemma":[0.9982246,0.0001427106,0.001007632,0.000040652,0.00001469699,0.0001759416,0.0002697708,0.000005096435,0.0001188677],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02131373,"threshold_uncertainty_score":0.1127192,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01017227258864854,"score_gpt":0.3021202913284249,"score_spread":0.2919480187397763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}